D'Silva Andrew J.
SEC insider (Form 3/4/5 filer). CIK 0002083717. Chief Business Officer at OptimizeRx Corp (OPRX). 9 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in WALTHAM, MA.
Companies D'Silva Andrew J. has filed insider reports for
- OptimizeRx Corp (OPRX): Officer, Chief Business Officer
D'Silva Andrew J.
CIK: 0002083717
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (22.2%)
Compensation grants
Other (G, F, J, C, D, …)7 (77.8%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OPRX
OptimizeRx Corp
Officer
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Oct 1, 2026OPRX
OptimizeRx Corp
Tax PaymentDirect414 shares at avg. $8.39$3K - Sep 1, 2026OPRX
OptimizeRx Corp
Tax PaymentDirect1.4K shares at avg. $7.86$11K - Aug 21, 2026OPRX
OptimizeRx Corp
Tax PaymentDirect1.2K shares at avg. $7.71$10K - Aug 20, 2026OPRX
OptimizeRx Corp
AwardDirect57.6K shares- - Dec 19, 2025OPRX
OptimizeRx Corp
Tax PaymentDirect703 shares at avg. $13.51$9K - Dec 11, 2025OPRX
OptimizeRx Corp
Tax PaymentDirect868 shares at avg. $14.03$12K - Oct 3, 2025OPRX
OptimizeRx Corp
Tax PaymentDirect794 shares at avg. $18.75$15K - Oct 1, 2025OPRX
OptimizeRx Corp
Tax PaymentDirect414 shares at avg. $18.98$8K - Aug 21, 2025OPRX
OptimizeRx Corp
AwardDirect10.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | OPRX OptimizeRx Corp | Tax Payment | 414 | $8.39 | $3,473 | Direct |
| Sep 1, 2026 | OPRX OptimizeRx Corp | Tax Payment | 1,432 | $7.86 | $11,256 | Direct |
| Aug 21, 2026 | OPRX OptimizeRx Corp | Tax Payment | 1,243 | $7.71 | $9,584 | Direct |
| Aug 20, 2026 | OPRX OptimizeRx Corp | Award | 57,600 | - | $0 | Direct |
| Dec 19, 2025 | OPRX OptimizeRx Corp | Tax Payment | 703 | $13.51 | $9,498 | Direct |
| Dec 11, 2025 | OPRX OptimizeRx Corp | Tax Payment | 868 | $14.03 | $12,178 | Direct |
| Oct 3, 2025 | OPRX OptimizeRx Corp | Tax Payment | 794 | $18.75 | $14,888 | Direct |
| Oct 1, 2025 | OPRX OptimizeRx Corp | Tax Payment | 414 | $18.98 | $7,858 | Direct |
| Aug 21, 2025 | OPRX OptimizeRx Corp | Award | 10,417 | - | - | Direct |
1-9 of 9 transactions